Publication | Closed Access
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.
15
Citations
0
References
2003
Year
Considering both the good activity and the low toxicity of this scheme, we think that it could be carried out in normal clinical practice.